Ann: Company Transformation Announcement, page-269

They’ve also committed $3 million over the three years to funding agreement for a research facility in Israel...

They haven’t yet turned a profit and made less than $40 000 in revenue according to last quarterly and they are once again pulling the dividend card but doing a capital raise to build a facility for a product that could take 8-10 years for any product to hit chemist shelves. Also the first million dollars of expenses need to be paid to Canntab as part of the deal there...

They’ve had their people in China with Bauxite samples spruiking that side. How’s that going to operate if it ever does? Another capital raise?

Maybe if the company can just show some clear projections about revenue and how the business will actually pay for day to day running of the business..

Just a few question marks on how all this is going to work.